Perrigo Co PLC

PRGO: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
%^LOCK|^^LOCK|m!NMd^n

Perrigo Earnings: Guidance Cut and Infant Formula Review Weigh on Shares

Perrigo reported third-quarter net sales down 4.1% year over year, driven by weak organic sales growth and the impact of divestitures and exited product line. Shares declined over 20% as management lowered its full-year outlook and announced a strategic review of the infant formula business.

Sponsor Center